About this document

Article Title: CMS National Coverage Policyo:p 1 by AdiaCostas is a document available to read on EtoBox.

The document outlines that ATP7B gene testing, associated with Wilson Disease, is considered a statutorily excluded service as current literature does not support its impact on treatment or patient outcomes. Claims for ATP7B gene tests should include specific CPT codes and modifiers, and an Advance Beneficiary Notice is not required. The article also provides guidance on billing and coding for these tests, including the necessary claim submission details.

Author

AdiaCostas

Language

EN